A placebo-controlled trial has shown that the oral AKT inhibitor engasertib could reduce the frequency and duration of ...
Several biopharma companies are working on compounds to inhibit AKT, a protein kinase that has been implicated in many cancers. Researchers at Mount Sinai Hospital in New York are pursuing a different ...
Linda Truebestein, Harald Hornegger, Dorothea Anrather, Markus Hartl, Kaelin D. Fleming, Jordan T. B. Stariha, Els Pardon, Jan Steyaert, John E. Burke, Thomas A ...
An aggressive breast cancer lacking common drug targets, triple-negative breast cancer may be countered by oridonin, a ...
Outcomes after autologous stem cell transplantation in relapsed or refractory Hodgkin disease: The Duke experience No significant financial relationships to disclose. This is an ASCO Meeting Abstract ...
Correlation between EGFR mutations and expression of female hormone receptors in NSCLC: A meta-analysis. This is an ASCO Meeting Abstract from the 2015 ASCO Annual Meeting I. This abstract does not ...
New research shows that a key protein in the brain called AKT may function differently in males than females. The study also offers a closer look at where, precisely, in the brain things may go wrong ...
In new research, scientists have found for the first time that disruptions to a particular protein called Akt can lead to the brain changes characteristic of bipolar disorder. The results offer a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback